Welcome to our dedicated page for PHIBRO ANIMAL HEALTH SEC filings (Ticker: PAHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PHIBRO ANIMAL HEALTH's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PHIBRO ANIMAL HEALTH's regulatory disclosures and financial reporting.
PHIBRO ANIMAL HEALTH CORP Executive Chairman and 10% owner Jack Bendheim reported the disposition of 2,303 shares of Class A Common Stock on August 4, 2026. According to the disclosure, these shares were sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the vesting and settlement of restricted stock units. Following this transaction, Bendheim directly holds 14,537 Class A shares, and an affiliated entity, BFI Co., LLC, holds 56,152 shares over which he exercises voting and dispositive power while disclaiming beneficial ownership except for his pecuniary interest.
Phibro Animal Health Corp officer Lisa Ann Escudero, Senior Vice President of Human Resources, had 265 shares of Class A Common Stock disposed of on August 4, 2026, at $36.599 per share in a broker-assisted cashless transaction to satisfy tax withholding on vested RSUs, leaving 1,887 shares held directly.
Phibro Animal Health Chief Operating Officer Larry Lee Miller reported a disposition of 635 shares of Class A Common Stock on August 4, 2026. The shares were sold at $36.599 per share in a broker-assisted cashless exercise to satisfy tax withholding obligations related to restricted stock unit vesting. Following the transaction, he directly held 34,549 shares.
PHIBRO ANIMAL HEALTH CORP executive Judith Weinstein reported an other disposition of 472 shares of Class A Common Stock on August 4, 2026, at $36.599 per share. According to the filing, these shares were sold in a broker-assisted cashless exercise to satisfy tax withholding obligations upon vesting and settlement of restricted stock units. Following this transaction, Weinstein directly held 2,975 shares of Class A Common Stock. The transaction was not reported as occurring under a Rule 10b5-1 trading plan.
Phibro Animal Health’s Chief Financial Officer David Glenn reported an other disposition of 840 shares of Class A Common Stock on 2026-08-04 at an average price of $36.599 per share. These shares were sold in a broker-assisted cashless exercise to satisfy tax withholding upon vesting of restricted stock units, leaving him with 51,477 shares directly owned.
Daniel M Bendheim, President and CEO of Phibro Animal Health, reported the sale of 486 shares of Class A Common Stock at $36.599 per share on 2026-08-04. The disclosure states that these shares were sold in a broker-assisted cashless transaction to satisfy tax withholding upon the receipt of shares from vesting of restricted stock units, leaving him with 3,478 shares held directly afterward.
Phibro Animal Health Corp has a significant shareholder position reported by FMR LLC and Abigail P. Johnson in an amended ownership filing. FMR LLC reports beneficial ownership of 3,160,280.92 shares of Class A common stock of Phibro Animal Health Corp, representing 15.0% of that class as of June 30, 2026. FMR LLC has sole voting power over 3,159,853 shares and sole dispositive power over 3,160,280.92 shares, with no shared voting or dispositive power. Abigail P. Johnson is reported as having sole dispositive power over the same 3,160,280.92 shares and a 15.0% beneficial ownership stake, with no voting power. The filing notes that one or more other persons may have rights to receive dividends or sale proceeds from these shares, but no such person holds more than 5% of the outstanding Class A common stock.